Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,862,222
-
Total 13F shares
-
21,243,183
-
Share change
-
+2,165,286
-
Total reported value
-
$277,395,506
-
Price per share
-
$13.01
-
Number of holders
-
37
-
Value change
-
+$28,289,369
-
Number of buys
-
25
-
Number of sells
-
9
Institutional Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q1 2025
As of 31 Mar 2025,
Benitec Biopharma Inc. - Common Stock (BNTC) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,243,183 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, INFINITUM ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.